V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003813 | 310001599 | 0 | 79.6 | Curative (C) | 2013-08-08 | 2013-08-12 | ECX | 2 | N | 310018683 | ECX |
| 310003814 | 310009109 | null | null | Palliative (P) | 2015-04-05 | 2015-04-13 | IPILIMUMAB + NIVOLUMAB | null | null | 310018687 | IPILIMUMAB + NIVOLUMAB |
| 310003815 | 310009109 | 0 | 0 | Neo-adjuvant (N) | 2014-01-02 | 2014-01-07 | Liposomal Doxorubicin 40mg/m2 | N | N | 310018687 | IMATINIB |
| 310003816 | 310009109 | 1.77 | 80.9 | null | 2017-08-12 | 2017-08-19 | IMATINIB | 02 | N | 310018687 | OXALIPLATIN + MDG |
| 310003817 | 310011448 | 1.88 | 99.2 | null | null | 2016-10-17 | Oxaliplatin + Modified de Gramont | N | N | 310018694 | EOX |
| 310003818 | 310001600 | 1.94 | 47 | Neo-adjuvant (N) | 2015-10-08 | 2015-10-22 | Mitomycin Intravesical | N | N | 310018695 | VEMURAFENIB |
| 310003819 | 310001601 | 1.69 | 58.4 | Adjuvant (A) | 2017-07-06 | 2017-07-06 | Capecitabine + Oxaliplatin 21day | 02 | N | 310018697 | DACARBAZINE |
| 310003820 | 310001602 | 0 | 84.4 | Palliative (P) | 2015-12-21 | 2016-01-05 | CHOEP - 21 days | 02 | N | 310018698 | PACLITAXEL |
| 310003821 | 310001603 | 0 | 61.2 | null | 2013-09-21 | 2013-09-22 | Oxaliplatin + Modified de Gramont | N | N | 310018701 | HYDROXYCARBAMIDE |
| 310003822 | 310001604 | null | 59 | Palliative (P) | 2017-01-20 | 2017-02-06 | null | 02 | N | 310018702 | NOT MATCHED |
| 310003823 | 310001604 | 1.55 | 50 | Palliative (P) | 2014-02-26 | 2014-02-27 | ECX | 02 | N | 310018702 | CAPECITABINE |
| 310003824 | 310001605 | 1.8 | null | Palliative (P) | null | 2016-11-03 | ECX | N | N | 310018704 | ECX |
| 310003825 | 310001605 | 1.77 | 76.4 | Palliative (P) | 2014-07-24 | 2014-08-04 | NB HRNBL-1 Isotretinoin | 2 | N | 310018704 | NOT MATCHED |
| 310003826 | 310001606 | 1.53 | 53.1 | Curative (C) | 2016-02-02 | 2016-02-05 | CISPLATIN + FLUOROURACIL | N | N | 310018706 | IMATINIB |
| 310003827 | 310001606 | 1.62 | 94.2 | Palliative (P) | 2016-11-19 | 2016-11-21 | Imatinib 400mg | N | N | 310018706 | IMATINIB |
| 310003828 | 310001606 | 1.8 | 79.3 | Disease modification (D) | 2014-10-17 | 2016-08-06 | null | N | N | 310018706 | NOT MATCHED |
| 310003829 | 310001606 | 1.82 | 78 | Neo-adjuvant (N) | 2015-03-20 | 2015-03-21 | Oxaliplatin + Modified de Gramont | 02 | N | 310018706 | CISPLATIN + FLUOROURACIL |
| 310003830 | 310001606 | 1.86 | null | Radical (R) | 2016-06-27 | 2016-07-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 310018706 | CAPECITABINE + OXALIPLATIN |
| 310003831 | 310001606 | null | null | Palliative (P) | 2013-10-08 | 2013-10-10 | null | null | null | 310018706 | NOT MATCHED |
| 310003832 | 310001607 | 1.56 | 88.1 | Palliative (P) | 2014-09-18 | 2014-09-19 | Bexarotene | null | null | 310018715 | IMATINIB |
| 310003833 | 310001607 | 1.57 | 80.3 | Curative (C) | 2015-08-13 | 2015-08-13 | Rituximab | N | N | 310018715 | EOX |
| 310003834 | 310001608 | 1.53 | 68 | Curative (C) | 2015-02-05 | 2015-03-22 | Capecitabine | N | N | 310018717 | BCG |
| 310003835 | 310001609 | 1.59 | 76 | Curative (C) | 2015-06-20 | 2015-06-20 | GEM-P | N | N | 310018718 | VEMURAFENIB |
| 310003836 | 310006708 | 0 | 74.9 | Curative (C) | 2016-09-28 | 2016-10-01 | CHOEP | N | N | 310018720 | CHOEP |
| 310003837 | 310006708 | 1.85 | 75.4 | Neo-adjuvant (N) | 2016-10-24 | 2016-10-26 | Rituximab | N | N | 310018720 | LIPOSOMAL DOXORUBICIN |
| 310003838 | 310006708 | 1.76 | null | Disease modification (D) | 2016-01-29 | 2016-02-02 | CHOEP - 14 days | 02 | N | 310018720 | CHOEP |
| 310003839 | 310001610 | null | null | Adjuvant (A) | 2015-02-04 | 2015-02-04 | Vemurafenib | 2 | null | 310018724 | ICON TRIAL |
| 310003840 | 310001610 | 1.73 | 61 | Disease modification (D) | 2017-08-30 | 2017-09-13 | Liposomal Doxorubicin (Caelyx) | Y | N | 310018724 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003841 | 310001610 | null | null | Palliative (P) | 2017-07-27 | 2017-08-18 | Capecitabine + Cisplatin | N | N | 310018724 | BCG |
| 310003842 | 310001610 | 1.64 | 88.3 | Palliative (P) | 2017-02-11 | 2017-02-12 | ALL UKALL2003 A: Ph VII Maint wk39+ | N | null | 310018724 | NOT MATCHED |
| 310003843 | 310001611 | 1.74 | null | Curative (C) | 2015-09-26 | 2015-10-14 | CYCLOPHOSPHAMIDE + DOXORUBICIN + EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | null | N | 310018731 | NOT MATCHED |
| 310003844 | 310001612 | 0 | 37.8 | Curative (C) | 2015-08-02 | 2015-08-10 | CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | N | N | 310018732 | NOT MATCHED |
| 310003845 | 310001613 | 1.73 | 82 | Curative (C) | 2017-06-05 | 2017-06-05 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 310018733 | NOT MATCHED |
| 310003846 | 310001613 | 1.81 | 75.7 | null | 2018-03-11 | 2018-03-11 | EOX | 02 | Y | 310018733 | CAPECITABINE + OXALIPLATIN |
| 310003847 | 310001613 | 1.69 | 89 | Curative (C) | 2015-03-02 | 2015-03-10 | IMATINIB | N | N | 310018733 | GEMCITABINE + PACLITAXEL |
| 310003850 | 310001615 | null | 92.3 | null | 2016-09-07 | 2016-09-10 | GEM-P | 2 | N | 310018742 | GEMCITABINE + PACLITAXEL |
| 310003851 | 310001615 | 1.68 | 104 | Palliative (P) | null | 2016-05-15 | ICON8 TRIAL | N | N | 310018742 | OXALIPLATIN + MDG |
| 310003852 | 310009114 | 1.59 | null | null | null | 2017-06-14 | CHOEP - 21 days | 02 | N | 310018745 | CHOEP |
| 310003853 | 310009114 | 1.76 | null | Curative (C) | 2016-08-13 | 2016-08-13 | CHOEP - 21 days | 02 | Y | 310018745 | CHOEP |
| 310003855 | 310001617 | null | 60.6 | null | 2014-06-29 | 2014-07-07 | CHOEP - 14 days | 02 | N | 310018751 | CHOEP |
| 310003856 | 310001618 | 1.88 | null | null | 2017-05-23 | 2017-05-23 | EOX | N | N | 310018760 | CISPLATIN + ETOPOSIDE |
| 310003858 | 310001620 | 1.77 | 80 | Neo-adjuvant (N) | 2014-09-04 | 2014-09-08 | ECX | N | N | 310018762 | ECX |
| 310003859 | 310006713 | 1.56 | 68 | Palliative (P) | 2016-05-30 | 2016-05-31 | ECX | N | null | 310018766 | ECX |
| 310003860 | 310006713 | 1.74 | 83.7 | Palliative (P) | 2014-07-16 | 2014-07-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310018766 | EOX |
| 310003861 | 310001621 | 1.78 | null | Palliative (P) | 2014-10-21 | 2014-10-27 | ECX | N | N | 310018768 | ECX |
| 310003862 | 310001621 | 1.81 | 82 | Palliative (P) | 2016-06-01 | 2016-06-01 | ECX | N | N | 310018768 | ECX |
| 310003863 | 310009116 | 1.76 | 89.4 | Adjuvant (A) | 2016-08-05 | 2016-10-07 | CHOEP - 14 days | N | N | 310018771 | CHOEP |
| 310003864 | 310009116 | 1.65 | 54 | Palliative (P) | 2016-06-18 | 2016-07-08 | null | N | N | 310018771 | NOT MATCHED |
| 310003865 | 310011059 | null | 76.1 | null | null | 2017-09-01 | Hydroxycarbamide | N | N | 310018775 | BEXAROTENE |
| 310003866 | 310011059 | 1.61 | 68 | Palliative (P) | 2015-04-03 | 2015-04-21 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018775 | OXALIPLATIN + MDG |